中美合资上海仁度生物科技有限公司是一家拥有核酸诊断技术自主知识产权的高科技企业。公司由美籍华裔科学家和国内企业家共同创建，致力于开发、推广以实时荧光核酸恒温扩增检测技术（简称SAT技术）为基础的核酸诊断产品。
公司位于中国药谷-上海张江医疗产业园。并在美国加州圣地亚哥设立了研发中心，利用美国加州完善的生物产业链，专注于新产品的前期研发和主要原材料的研究与供应。
本着创新、务实、国际化的理念，我们期待更多的人才加入到我们的团队中，在这个既有创业激情，又有踏实工作作风的团队，我们将为每一位员工搭建成就美好事业的平台。
Shanghai Rendu Biotechnology Co., Ltd. is a Joint Venture company with US that devotes to promoting nucleic acid diagnosis series products using Simultaneous Amplification and Testing Technique. Our series products apply in pathogenic microorganisms clinical examination, blood screening, and environment microorganisms examination etc.
Rendu is located in Chinese medicine valley—Zhangjing High-tech park, and has set up a R&D center in San Diego California US. Rendu R&D center concentrates in the new product pre-R&D, the main raw material research and supply, using consummate Biological industry chain in California.
With Innovation, Pragmaticalness, Internationalization idea, we hope more outstanding people join in our team. We will build an achievement platform for each staff.